Blood pressure control and left ventricular mass in children with chronic kidney disease

Manish D Sinha1, Shane M Tibby, Pernille Rasmussen

  • 1Department of Pediatric Nephrology, Evelina Children's Hospital, Guy's & St Thomas' NHS Foundation Trust, London SE1 7EH, UK. manish.sinha@gstt.nhs.uk

Insights

Left ventricular hypertrophy (LVH) is common in children with chronic kidney disease (CKD). Even without overt hypertension, higher blood pressure (BP) and calcium intake are linked to LVH, suggesting current BP targets may need re-evaluation.

Area of Science:

  • Pediatric Nephrology
  • Cardiology
  • Hypertension Research

Background:

  • Heart disease is a leading cause of mortality in young adults with chronic kidney disease (CKD).
  • Left ventricular hypertrophy (LVH), a thickening of the heart's main pumping chamber, is prevalent in children with CKD and often linked to hypertension.
  • The appropriateness of current blood pressure (BP) control targets in pediatric CKD requires investigation.

Purpose of the Study:

  • To investigate the relationship between LVH and BP in children with CKD.
  • To determine if existing BP control targets are adequate for this population.
  • To explore potential contributing factors to LVH in pediatric CKD.

Main Methods:

  • A single-center, cross-sectional study involving 49 nonhypertensive children with CKD.
  • Echocardiography was used to assess left ventricular mass index (LVMI).
  • Clinic and 24-hour ambulatory BP monitoring were performed, alongside analysis of biochemical data and prior BP records.

Main Results:

  • Nearly half (49%) of the children exhibited LVH, with a mean LVMI of 37.8 ± 9.1 g/m²·⁷.
  • Children with LVH had higher BP readings than those without, despite not meeting criteria for overt hypertension.
  • Systolic BP, particularly clinic measurements, showed a strong correlation with LVMI. Elemental calcium intake was also positively associated with LVMI.

Conclusions:

  • LVH is associated with elevated systolic BP in pediatric CKD patients, even without overt hypertension.
  • Current BP control targets in children with CKD may need re-evaluation.
  • The link between LVH and elemental calcium intake raises concerns about the use of calcium-based phosphate binders in this patient group.
Abstract

Related Concept Videos

Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Blood Pressure01:30

Blood Pressure

Blood pressure (BP) is the pressure or force of blood exerted on the artery's walls as it circulates through the body. It is essential for maintaining blood flow throughout the body.
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...